RETRACTED: Lai et al. MicroRNA-21 Plays Multiple Oncometabolic Roles in the Process of NAFLD-Related Hepatocellular Carcinoma via PI3K/AKT, TGF-β, and STAT3 Signaling. Cancers 2021, 13, 940

Lai, Chi-Yu; Yeh, Kun-Yun; Lin, Chiu-Ya; Hsieh, Yang-Wen; Lai, Hsin-Hung; Chen, Jim-Ray; Hsu, Chia-Chun; Her, Guor Mour

doi:10.3390/cancers16081597

Open AccessRetraction

RETRACTED: Lai et al. MicroRNA-21 Plays Multiple Oncometabolic Roles in the Process of NAFLD-Related Hepatocellular Carcinoma via PI3K/AKT, TGF-β, and STAT3 Signaling. Cancers 2021, 13, 940

by

Chi-Yu Lai

^1,2,3,†

,

Kun-Yun Yeh

^4,†

,

Chiu-Ya Lin

^1,2,3,

Yang-Wen Hsieh

^1,2,3,

Hsin-Hung Lai

^2,3,

Jim-Ray Chen

⁵,

Chia-Chun Hsu

^6,7 and

Guor Mour Her

^2,3,*

¹

Department of Bioscience and Biotechnology, National Taiwan Ocean University, Keelung 202, Taiwan

²

Institute of Biopharmaceutical Sciences, National Yang Ming Chiao Tung University, Taipei 112, Taiwan

³

Institute of Biopharmaceutical Sciences, National Yang-Ming University, Taipei 112, Taiwan

⁴

Division of Hemato-Oncology, Department of Internal Medicine, Chang Gung Memorial Hospital, Keelung 204, Taiwan

⁵

Department of Pathology, Chang Gung Memorial Hospital, Keelung 204, Taiwan

⁶

Department of Radiology, Buddhist Tzu Chi General Hospital, Taichung Branch, Taichung 427, Taiwan

⁷

School of Medicine, Tzu Chi University, Hualien 970, Taiwan

^*

Author to whom correspondence should be addressed.

^†

These authors contributed equally to this work.

Cancers 2024, 16(8), 1597; https://doi.org/10.3390/cancers16081597

Submission received: 3 April 2024 / Accepted: 9 April 2024 / Published: 22 April 2024

Download Versions Notes

The Cancers Editorial Office retracts the article, “MicroRNA-21 Plays Multiple Oncometabolic Roles in the Process of NAFLD-Related Hepatocellular Carcinoma via PI3K/AKT, TGF-β, and STAT3 Signaling” [1], as cited above.

Following publication, concerns were brought to the attention of the publisher regarding overlapping panels contained within this article [1].

Adhering to our complaint procedure, an investigation was conducted by the Editorial Board and the Editorial Office that confirmed an overlap of panels contained in Figures 5D and 6C,D, representing different experimental conditions. While the authors proactively cooperated with the investigation, the authors were unable to satisfactorily explain the overlapping elements within the above-mentioned figures, nor could they provide raw material to validate these findings. As a result, the Editorial Board and Editor-in-Chief were unable to confirm the reliability of the findings and subsequently decided to retract this article [1], as per MDPI’s retraction policy (https://www.mdpi.com/ethics#_bookmark30, accessed on 8 April 2024) and in line with the Committee on Publication Ethics retraction guidelines (https://publicationethics.org/retraction-guidelines, accessed on 8 April 2024).

This retraction was approved by the Editor-in-Chief of Cancers.

The authors agree with this retraction.

Reference

Lai, C.-Y.; Yeh, K.-Y.; Lin, C.-Y.; Hsieh, Y.-W.; Lai, H.-H.; Chen, J.-R.; Hsu, C.-C.; Her, G.M. RETRACTED: MicroRNA-21 plays multiple oncometabolic roles in the process of NAFLD-related hepatocellular carcinoma via PI3K/AKT, TGF-β, and STAT3 signaling. Cancers 2021, 13, 940. [Google Scholar] [CrossRef] [PubMed]

Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

Share and Cite

MDPI and ACS Style

Lai, C.-Y.; Yeh, K.-Y.; Lin, C.-Y.; Hsieh, Y.-W.; Lai, H.-H.; Chen, J.-R.; Hsu, C.-C.; Her, G.M. RETRACTED: Lai et al. MicroRNA-21 Plays Multiple Oncometabolic Roles in the Process of NAFLD-Related Hepatocellular Carcinoma via PI3K/AKT, TGF-β, and STAT3 Signaling. Cancers 2021, 13, 940. Cancers 2024, 16, 1597. https://doi.org/10.3390/cancers16081597

AMA Style

Lai C-Y, Yeh K-Y, Lin C-Y, Hsieh Y-W, Lai H-H, Chen J-R, Hsu C-C, Her GM. RETRACTED: Lai et al. MicroRNA-21 Plays Multiple Oncometabolic Roles in the Process of NAFLD-Related Hepatocellular Carcinoma via PI3K/AKT, TGF-β, and STAT3 Signaling. Cancers 2021, 13, 940. Cancers. 2024; 16(8):1597. https://doi.org/10.3390/cancers16081597

Chicago/Turabian Style

Lai, Chi-Yu, Kun-Yun Yeh, Chiu-Ya Lin, Yang-Wen Hsieh, Hsin-Hung Lai, Jim-Ray Chen, Chia-Chun Hsu, and Guor Mour Her. 2024. "RETRACTED: Lai et al. MicroRNA-21 Plays Multiple Oncometabolic Roles in the Process of NAFLD-Related Hepatocellular Carcinoma via PI3K/AKT, TGF-β, and STAT3 Signaling. Cancers 2021, 13, 940" Cancers 16, no. 8: 1597. https://doi.org/10.3390/cancers16081597

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Menu

RETRACTED: Lai et al. MicroRNA-21 Plays Multiple Oncometabolic Roles in the Process of NAFLD-Related Hepatocellular Carcinoma via PI3K/AKT, TGF-β, and STAT3 Signaling. Cancers 2021, 13, 940

Reference

Share and Cite

Article Metrics

Article Access Statistics

Further Information

Guidelines

MDPI Initiatives

Follow MDPI